Featured Publication in the ScienceDirect Journal by Dr. Bustamante, Luis O. Chavez, MD, and Marc J. Zuckerman MD.

Endoscopic Bariatric Interventions in Patients with Chronic Liver Disease

Key points

• Endoscopic bariatric interventions are effective in treating obesity and associated comorbidities, including chronic liver disease secondary to metabolic associated fatty liver disease (MAFLD).
•  All endoscopic bariatric interventions should be used concomitantly with moderate- to high-intensity lifestyle modifications in patients in whom conventional weight-loss strategies have failed.
•  Gastric endoscopic bariatric interventions, in particular, intragastric balloons, have demonstrated to be effective in improving liver-related outcomes.
•  Small bowel endoscopic bariatric interventions have had positive results for the treatment of obesity and associated comorbidities, including MAFLD.
•  There is a lack of studies in the setting of cirrhosis and liver transplantation.